{"id":"W4225684867","doi":"10.1097/01.ogx.0000805152.09501.f1","title":"Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer","year":2022,"lang":"en","type":"article","venue":"Obstetrical & Gynecological Survey","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université Laval; Centre Hospitalier de l’Université de Montréal; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Pembrolizumab; Bevacizumab; Oncology; Chemotherapy; Cervical cancer; Internal medicine; Paclitaxel; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008164791,0.0002818209,0.0007120895,0.0001549542,0.0004564307,0.00003730261,0.0003167581,0.0001127031,0.01855367],"category_scores_gemma":[0.003864468,0.0001897675,0.0006173753,0.001384901,0.0001411663,0.00004698003,0.0002026757,0.0004993218,0.00002306552],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000981177,"about_ca_system_score_gemma":0.0003466464,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003332286,"about_ca_topic_score_gemma":0.0002180427,"domain_scores_codex":[0.9968619,0.0006507054,0.000565122,0.0006410692,0.0006049974,0.0006761593],"domain_scores_gemma":[0.9938185,0.005216099,0.0001589101,0.0003113835,0.0001766124,0.0003185413],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.1445401,0.01087238,0.2234932,0.0006208687,0.003206615,0.000631208,0.000457079,0.0001689926,0.001519638,0.0003976621,0.1223051,0.4917872],"study_design_scores_gemma":[0.01251008,0.01143992,0.6624665,0.00001741192,0.0003735793,0.0001077152,0.0003271443,0.001326224,0.00004002078,0.00006905763,0.3108035,0.0005188432],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9608803,0.01973171,0.0003806272,0.005090207,0.004622628,0.004489756,0.0024154,0.0003600807,0.002029282],"genre_scores_gemma":[0.9893222,0.0003392322,0.0005591183,0.002917301,0.0001003797,0.00127095,0.0003568148,0.00003962763,0.005094305],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4912683,"threshold_uncertainty_score":0.9823435,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1206040151824032,"score_gpt":0.3571078776410807,"score_spread":0.2365038624586774,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}